Correlation Between Cyclooxygenase-2 Expression and HuR Cytoplasmic Translocation of Breast Cancer
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background : Embryonic lethal abnormal vision (ELAV)-like protein HuR is known to stabilize mRNA through binding AU-rich elements in the 3’-untranslated region. Recent studies show that HuR expression is associated with the expression of several genes including cyclooxygenase- 2 (COX-2). HuR exists predominantly in the nucleus, but cytoplasmic translocation of HuR is thought to be more important for its activity. COX-2 is a well-known enzyme that promotes tumor growth. Methods : To evaluate the correlation of HuR and COX-2 expression, we analyzed expression of HuR and COX-2 in 91 cases of breast cancer using immunohistochemistry. Results : Nuclear and cytoplasmic expression of HuR was seen in 76 (83.5%) and 19 (20.9%) of 91 cases respectively. COX-2 immunoreactivity was seen in 54 (59.4%) cases. Cytoplasmic HuR expression showed significant correlation with COX-2 expression (p=0.001). Nuclear HuR showed no correlation with COX-2 expression or other clinicopathological parameters. COX-2 expression is significantly associated with tumor grade (p=0.028). COX-2 (p=0.092) and cytoplasmic (p=0.569) and nuclear HuR (p=0.247) expression showed no correlation with survival. Conclusions : These results suggest that cytoplasmic HuR expression is associated with COX-2 expression in breast cancer and cytoplasmic location of HuR might contribute to the stabilization of COX-2 mRNA.
Abstract
Background : Embryonic lethal abnormal vision (ELAV)-like protein HuR is known to stabilize mRNA through binding AU-rich elements in the 3’-untranslated region. Recent studies show that HuR expression is associated with the expression of several genes including cyclooxygenase- 2 (COX-2). HuR exists predominantly in the nucleus, but cytoplasmic translocation of HuR is thought to be more important for its activity. COX-2 is a well-known enzyme that promotes tumor growth. Methods : To evaluate the correlation of HuR and COX-2 expression, we analyzed expression of HuR and COX-2 in 91 cases of breast cancer using immunohistochemistry. Results : Nuclear and cytoplasmic expression of HuR was seen in 76 (83.5%) and 19 (20.9%) of 91 cases respectively. COX-2 immunoreactivity was seen in 54 (59.4%) cases. Cytoplasmic HuR expression showed significant correlation with COX-2 expression (p=0.001). Nuclear HuR showed no correlation with COX-2 expression or other clinicopathological parameters. COX-2 expression is significantly associated with tumor grade (p=0.028). COX-2 (p=0.092) and cytoplasmic (p=0.569) and nuclear HuR (p=0.247) expression showed no correlation with survival. Conclusions : These results suggest that cytoplasmic HuR expression is associated with COX-2 expression in breast cancer and cytoplasmic location of HuR might contribute to the stabilization of COX-2 mRNA.
참고문헌 (27)
- Chen CY, "AU-rich elements: characterization and importance in mRNA degradation", Trends Biochem Sci, 20, pp.465~470 (1995)
- Brennan CM, "HuR and mRNA stability", Cell Mol Life Sci, 58, pp.266~277 (2001)
- Barreau C, "AU-rich elements and associated factors: are there unifying principles?", Nucleic Acids Res, 33, pp.7138~7150 (2005)
- Good PJ, "The role of elav-like genes, a conserved family encoding RNA-binding proteins, in growth and development", Semin Cell Dev Biol, 8, pp.577~584 (1997)
- Ma WJ, "Cloning and characterization of HuR, a ubiquitously expressed ELAV-like protein", J Biol Chem, 271, pp.8144~8151 (1996)
- Nagaoka K, "Stability of casein mRNA is ensured by structural interactions between the 3’- untranslated region and poly (A) tail via the HuR and poly (A)-bindingprotein complex", Biochim Biophys Acta, 1759, pp.132~140 (2006)
- Wang W, "HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation", EMBO J, 19, pp.2340~2350 (2000)
- Wein G, "The 3’-UTR of the mRNA coding for the major protein kinase C substrate MARCKS contains a novel CU-rich element interacting with the mRNA stabilizing factors HuD and HuR", Eur J Biochem, 270, pp.350~365 (2003)
- Kawai T, "Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR", Mol Cell Biol, 26, pp.3295~3307 (2006)
- Sengupta S, "The RNAbinding protein HuR regulates the expression of cyclooxygenase-2", J Biol Chem, 278, pp.25227~25233 (2003)
- Fan XC, "Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs", EMBO J, 17, pp.3448~3460 (1998)
- Tatsuguchi A, "Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue", Hum Pathol, 35, pp.488~495 (2004)
- Tsujii M, "Cyclooxygenase-2 expression inhuman colon cancer cells increases metastatic potential", Proc Natl Acad Sci USA, 94, pp.3336~3340 (1997)
- Sutton KM, "Cyclooxygenase- 2 expression in chondrosarcoma", Oncology, 66, pp.275~280 (2004)
- Denkert C, "Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma", Cancer, 97, pp.2978~2987 (2003)
- Zerkowski MP, "Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome", Cancer Invest, 25, pp.19~26 (2007)
- Singh B, "COX-2 overexpression increases motility and invasion of breast cancer cells", Int J Oncol, 26, pp.1393~1399 (2005)
- Denkert C, "Expression of the ELAVlike protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2", Mod Pathol, 19, pp.1261~1269 (2006)
- Mrena J, "Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR", Clin Cancer Res, 11, pp.7362~7368 (2005)
- Denkert C, "Overexpression of the embryonic- lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression", Cancer Res, 64, pp.189~195 (2004)
- Erkinheimo TL, "Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma", Cancer Res, 63, pp.7591~7594 (2003)
- Denkert C, "Expression of the ELAVlike protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma", Clin Cancer Res, 10, pp.5580~5586 (2004)
- Wang W, "AMP-activated kinase regulates cytoplasmic HuR", Mol Cell Biol, 22, pp.3425~3436 (2002)
- Wang W, "HuR regulates p21 mRNA stabilization by UV light", Mol Cell Biol, 20, pp.760~769 (2000)
- Atasoy U, "ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation", J Cell Sci, 111, pp.3145~3156 (1998)
- Subbaramaiah K, "Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR", J Biol Chem, 278, pp.37637~37647 (2003)
- Tran H, "Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2", Mol Cell Biol, 23, pp.7177~7188 (2003)